Navigation Links
CV Therapeutics and Astellas Announce FDA Approval for Lexiscan(TM) (regadenoson) Injection
Date:4/10/2008

atients unable to exercise adequately. The most common side effects include flushing, chest discomfort and dyspnea. Less frequent side effects reported in patients administered Adenoscan include second and third degree AV block, fatal cardiac arrest, ventricular tachycardia and nonfatal myocardial infarction. For full prescribing information, please visit http://www.adenoscan.com.

About CV Therapeutics

CV Therapeutics, Inc., headquartered in Palo Alto, California, is a biopharmaceutical company primarily focused on applying molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases.

CV Therapeutics' approved products include Ranexa(R) (ranolazine extended- release tablets), indicated for the treatment of chronic angina in patients who have not achieved an adequate response with other antianginal drugs, and Lexiscan(TM) (regadenoson) injection for use as a pharmacologic stress agent in radionuclide myocardial perfusion imaging. CV Therapeutics also has other clinical and preclinical drug development candidates and programs.

CV Therapeutics Conference Call

Company management will webcast a conference call on Friday, April 11, 2008 at 8:30 a.m. EDT, 5:30 a.m. PDT, on the company's website. To access the live webcast and corresponding slides, please log on to the Company's website at http://www.cvt.com and go to the Investor Information section. Alternatively, domestic callers may participate in the conference call by dialing (866) 524-6241, and international callers may participate in the conference call by dialing (706) 679-3061. Webcast and telephone replays of the conference call will be available approximately two hours after the completion of the call through Friday, April 18, 2008. Domestic callers can access the replay by dialing (800) 642-1
'/>"/>

SOURCE Astellas Pharma US, Inc.
Copyright©2008 PR Newswire.
All rights reserved

3

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Stemline Therapeutics Raises $12.5 Million
2. Lorus Therapeutics Announces Exclusive Multinational License Agreement with Zoticon Bioventures for Virulizin(R)
3. Amsterdam Molecular Therapeutics Part of Next Biotech Index
4. Sirion Therapeutics Highlights Pivotal Trial Results of Durezol(TM) at the American Society of Cataract and Refractive Surgery Annual Symposium
5. Alba Therapeutics Announces Appointment of Bruce A. Peacock as its Chief Executive Officer
6. Amsterdam Molecular Therapeutics to Appoint George Morstyn to Supervisory Board
7. DiObex Announces Presentation of Scientific Poster at Annual Meeting of American Society for Clinical Pharmacology and Therapeutics
8. ImaRx Therapeutics Reports Business Update and Financial Results for Fourth Quarter and Full Year 2007
9. Mercury Therapeutics Patents Filed
10. Cell Therapeutics, Inc. Announces Filing of Form 10-K
11. Vicus Therapeutics Announces Participation at 15th International Molecular Medicine Tri-Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...loyment grew by 29,000 jobs in October, and the f...h during the U.S. recession. However, clinics and ...systems are coming closer to having to actually cu...s. , (Vocus) November 24,...in October despite the shedding of jobs in most ot...
(Date:11/24/2009)...NODPharmaceuticalsInc.announced,theUSPatent&Tr...r,itsnano-particleoraldeliveryorNODtechnology. ,...poratepeptidesor,proteinsintobio-adhesivenano-part...eredasinjections.NODtechnologyisaplatformtechnolog...nsulin,interferon,growthhormone,exenatide,heparin...
(Date:11/24/2009)...ShanghaiBiolaxyannouncedthe,ChineseStateFood&D...nalnewdrugapplication(IND)foritsoralinsulinproject...betes.ThisIND,approvalallowsBiolaxytoinitiateitsfi...characteristicofhighbloodglucoseandpoor,metabolism...o-and,macro-vasculardiseases,lossofvision,kidneyfa...
(Date:11/24/2009)... approved the Promega PowerPlex 16 HS System for u...DNA records for the National DNA Index System. , ... The FBI recently approved the Promega PowerPlex&...pating in, or generating DNA records for, the Nati...ins more than seven million profiles and has assis...
Breaking Biology Technology:The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4Biolaxy Secures IND Approval for Oral Insulin 2NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database 2
..., , , , , , , Multipo... , , , , , .... 4308 915.531 12/2001 , , , ..., , Microorganism , ..., Cell type , Yeast, ...
..., , , , , , , Multipo... , , , , , .... 4308 915.526 01/2002 , , , ..., , Microorganism , ... Cell type , Bacteria, gram positi...
..., , , , , , , Multipo... , , , , , .... 4308 915.521 02/2002 , , , ..., , Microorganism , ... , Cell type , Bacter...
Other Biology Technology:Saccharomyces cerevisiae 2Nocardia corallina 2Mycobacterium intracellulare 2
(Date:11/24/2009)...hat constitutes fish food is a matter of debate. A... fish get almost 50 percent of their carbon from t...tween the terrestrial and aquatic ecosystems. , ... shows this is not likely to be true. Algae provid...fe, according to research published this week in t...
(Date:11/23/2009)..., Cambridge, Mass. November 23, 2009 Applied mat...in lily ( Hosta lancifolia ), a characteristic lon...ly packed ripples along the edges. The simple caus...esulting from bending during differential growthwa...tretching foam ribbons. , Haiyi Liang, a postdoc...
(Date:11/23/2009)...CHAMPAIGN, Ill. A new study provides "incontrover...f Toba on the island of Sumatra about 73,000 years...miles from the epicenter, researchers report. , ...ers of ash into the atmosphere, leaving a crater (... kilometers long and 35 kilometers wide. Ash from ...
Breaking Biology News(10 mins):Fish food fight: Fish don't eat trees after all, says new study 2Fish food fight: Fish don't eat trees after all, says new study 3The cause behind the characteristic shape of a long leaf revealed 2Supervolcano eruption -- in Sumatra -- deforested India 73,000 years ago 2Water conserving irrigation strategies minimize overwatering runoff 60696 1Water conserving irrigation strategies minimize overwatering runoff 60696 2Water conserving irrigation strategies minimize overwatering runoff 60696 3Common plants can eliminate indoor air pollutants 60694 1Common plants can eliminate indoor air pollutants 60694 2When should flu trigger a school shutdown 3F 60692 1When should flu trigger a school shutdown 3F 60692 2When should flu trigger a school shutdown 3F 60692 3
... University have developed a technique that has th...seased areas within hours, as opposed to the two d...ms. , Using laboratory mice, drug delivery time fr...two days to mere hours. Using this as a model for ...oon receive the benefits of cancer-fighting drugs ...
... identified a protein able to stimulate the produc... the recognition and the elimination of infectious...tute for Research in Immunology and Cancer (IRIC) ...ersity of Oulu in Finland published in the latest...combat age-related declines in immune response. , ...
... at The University of Texas at Austin is part of a...ane that should simplify the water desalination pr...ly reducing greenhouse gases. , "If we make the d...branes, it will be less expensive to desalinate a ...y of clean water around the world," Professor Benn...
Other Biology News:Cancer drug delivery research at Case Western Reserve University cuts time from days to hours 2Cancer drug delivery research at Case Western Reserve University cuts time from days to hours 3Identification of protein able to stimulate production of T-cells 2New chlorine-tolerant, desalination membrane hopes to boost access to clean water 2
Mouse Anti-Human PARK2 Monoclonal Antibody, Unconjugated, Clone 1H4 from Novus Biologicals
Rabbit Anti-NMDA NR2B, phospho (Tyr1336) Polyclonal Antibody, Unconjugated from Novus Biologicals
MTT Reagent A from CHEMICON
Mouse Anti-Human ALS2CR8 Polyclonal Antibody, Unconjugated from Novus Biologicals
Biology Products: